Suppr超能文献

乳腺癌细胞中的微小RNA网络

MicroRNA Networks in Breast Cancer Cells.

作者信息

Tahiri Andliena, Aure Miriam R, Kristensen Vessela N

机构信息

Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway.

Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Ullernchausseen 70, 0379, Oslo, Norway.

出版信息

Methods Mol Biol. 2018;1711:55-81. doi: 10.1007/978-1-4939-7493-1_4.

Abstract

A variety of molecular techniques can be used in order to unravel the molecular composition of cells. In particular, the microarray technology has been used to identify novel biomarkers that may be useful in the diagnosis, prognosis, or treatment of cancer. The microarray technology is ideal for biomarker discovery as it allows for the screening of a large number of molecules at once. In this review, we focus on microRNAs (miRNAs) which are key molecules in cells and regulate gene expression post-transcriptionally. miRNAs are small, single-stranded RNA molecules that bind to complementary mRNAs. Binding of miRNAs to mRNAs leads either to degradation, or translational inhibition of the target mRNA. Roughly one third of all the mRNAs are postulated to be regulated by miRNAs. miRNAs are known to be deregulated in different types of cancer, including breast cancer, and it has been demonstrated that deregulation of several miRNAs can be used as biological markers in cancer. miRNA expression can for example discriminate between normal, benign and malignant breast tissue, and between different breast cancer subtypes.In the post-genomic era, an important task of molecular biology is to understand gene regulation in the context of biological networks. Because miRNAs have such a pronounced role in cells, it is pivotal to understand the mechanisms that underlie their control, and to identify how miRNAs influence cancer development and progression.

摘要

为了阐明细胞的分子组成,可以使用多种分子技术。特别是,微阵列技术已被用于识别可能在癌症诊断、预后或治疗中有用的新型生物标志物。微阵列技术是生物标志物发现的理想选择,因为它允许一次性筛选大量分子。在本综述中,我们重点关注微小RNA(miRNA),它们是细胞中的关键分子,在转录后调节基因表达。miRNA是与互补mRNA结合的小单链RNA分子。miRNA与mRNA的结合导致靶mRNA的降解或翻译抑制。据推测,所有mRNA中约有三分之一受miRNA调控。已知miRNA在包括乳腺癌在内的不同类型癌症中失调,并且已经证明几种miRNA的失调可作为癌症的生物标志物。例如,miRNA表达可以区分正常、良性和恶性乳腺组织,以及不同的乳腺癌亚型。在后基因组时代,分子生物学的一项重要任务是在生物网络的背景下理解基因调控。由于miRNA在细胞中具有如此显著的作用,了解其控制机制以及确定miRNA如何影响癌症的发生和发展至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验